VacZine Analytics  
MarketVIEW: Norovirus vaccines

Updated: October 2015

Noroviruses (NVs) called "Norwalk-like viruses" are a group of single-stranded positive sense RNA viruses and members of the family Caliciviridae. NVs are transmitted from human-to-human and are one of the most highly infectious viruses known. In the community, NVs most commonly cause a self-limiting mild disease of short duration with gastrointestinal symptoms usually resolving after 1 to 3 days. However, it is the sheer volume of infections and burden on healthcare systems that presents the biggest challenge. In the US, which does not yet have active national surveillance, norovirus infections may account for an estimated 1.8 million outpatient visits, 400,000 emergency department visits, 56,000-71,000 hospitalizations and 570-800 deaths. NV outbreaks are also a well known issue for military installations and commercial cruise ship liners.

This MarketVIEW product is a comprehensive MS Excel-based model + summary presentation which forecasts the potential commercial value of Norovirus vaccines across major Western and emerging markets to 2035. The model contains value ($ m) and volume (mio doses) predictions along with launch timeframe, TPP, pricing and penetration estimates. LO/BASE/HI forecast scenarios are included based upon the level of populations targeted by a potential vaccine.


To order please contact your region account manager, buy "on-line" or order direct at:

VAMV015 Click here>>
Choose option:
*Prices quotes are for 1 region license only. Regions are North America, or EU or ROW. For UK orders VAT will be added at 20%. Please review the TERMS and CONDITIONS of purchase.

Return to main list>> Questions about this report?

© 2014 VacZine Analytics. All rights reserved. Disclaimer | Privacy | Terms and conditions. hosted by chillydomains